MedTrace Logo

The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis

NCT01318954 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2015-10-29

No results posted yet for this study

Summary

This study will evaluate whether exhaled nitric oxide levels are affected by allergen immunotherapy ("allergy shots"). The investigators' hypothesis is that successful allergen immunotherapy may be accompanied by decreased exhaled nitric oxide levels.

Conditions

  • Allergic Asthma
  • Allergic Rhinitis

Interventions

BIOLOGICAL

Allergen immunotherapy

Sponsors & Collaborators

  • Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.

    lead OTHER

Principal Investigators

  • Michele Columbo, M.D. · Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01318954 on ClinicalTrials.gov